SCHEMBL28347236

SCHEMBL28347236

COP(=O)(OC)Oc1ccccc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
ADRA2B P18089 1/20 0.54
PTGS1 P23219 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
LMNA P02545 2/20 0.43
RECQL P46063 1/20 0.43
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TSHR P16473 1/20 0.38
CFTR P13569 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GAA P10253 2/20 0.37
RCE1 Q9Y256 2/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699762 0.87 ALDH1A1 (0.50) ALDH1A1ADRA2BPTGS1TDP1LMNA
SCHEMBL5334635 0.83 ALDH1A1 (0.46) ALDH1A1ADRA2BPTGS1TDP1LMNA
SCHEMBL28790810 0.80 ALDH1A1 (0.43) ALDH1A1ADRA2BPTGS1TDP1LMNA
SCHEMBL30118861 0.79 ALDH1A1 (0.52) ALDH1A1ADRA2BPTGS1TDP1LMNA
SCHEMBL27430826 0.78 KDM4E (0.46) ALDH1A1LMNACYP1A2CYP2C9CYP2C19
SCHEMBL31306469 0.76 LMNA (0.50) ALDH1A1TDP1LMNACYP1A2CYP2C9
SCHEMBL31306482 0.76 CA1 (0.54) ALDH1A1TDP1LMNAKDM4EMAPT
SCHEMBL3222697 0.76 LMNA (0.60) TDP1LMNAMAPTSMN1; SMN2TSHR
SCHEMBL27846610 0.76 MEN1 (0.39) CYP1A2CYP2C9CYP2C19MAPTCRHBP
SCHEMBL569537 0.75 INPPL1 (0.57) ALDH1A1ADRA2BPTGS1TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108350006-B Deuterium-modified Brigatinib derivative, pharmaceutical composition containing compound and application of deuterium-modified Brigatinib derivative 正大天晴药业集团股份有限公司 2020-01-03 CN disclosed